CRVS vs HAL · $1.04B cap vs P/E 9.3, $19.05B cap
Corvus Pharmaceuticals Inc (CRVS) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
Corvus Pharmaceuticals Inc (CRVS) is a biotechnology company listed on US.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
CRVS does not have a complete income-statement cache yet.
HAL does not have a complete income-statement cache yet.
CRVS currently screens at market cap $1.04B. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the CRVS and HAL stock pages for the full models.
Not investment advice.